Providers Clinical Support System Substance Use Disorder Treatment (PCSS-SUD Treatment)

The Providers Clinical Support System – Substance Use Disorder Treatment (PCSS-SUD Treatment) is a forthcoming federal funding opportunity administered by the Substance Abuse and Mental Health Services Administration (SAMHSA), an agency within the U.S. Department of Health and Human Services. This program is part of a broader federal initiative to expand access to evidence-based treatment for substance use disorders (SUDs) by equipping healthcare and counseling professionals with the training, technical assistance, and mentorship needed to provide effective SUD care across general and behavioral health settings. The primary objective of this cooperative agreement is to build capacity within the healthcare system by supporting providers in integrating SUD treatment services into their existing practices. This is especially crucial given the ongoing national efforts to combat the opioid epidemic and address other substance use issues that significantly impact public health. Through this program, SAMHSA aims to increase the number of general and specialty healthcare practices that are equipped to identify, manage, and treat patients with SUDs, thereby reducing barriers to treatment and improving health outcomes. The funding will support a national training and technical assistance center responsible for delivering comprehensive services that may include curriculum development, interactive and on-demand learning platforms, tele-mentoring programs, resource development, and dissemination of best practices. Emphasis will likely be placed on evidence-based interventions, culturally competent care, and integration of behavioral health into primary care. Although specific spending rules and deliverables are not yet detailed, cooperative agreements of this nature typically include strong oversight and collaborative planning with the federal agency. Eligibility for the PCSS-SUD Treatment program is limited to domestic public and private nonprofit entities, including professional organizations that fall within the scope of the Medication Access and Training Expansion (MATE) Act. This focus suggests that applicants must demonstrate strong institutional capacity to deliver nationwide support services and possess a track record in healthcare education and behavioral health. For-profit entities and individuals are not eligible to apply. As a forecasted opportunity, the official notice of funding opportunity (NOFO) has not yet been posted, and detailed application instructions, submission requirements, and evaluation criteria are forthcoming. Based on standard SAMHSA procedures, applications will likely need to be submitted through Grants.gov, including organizational documentation, a detailed project narrative, budget justification, and performance measurement tools. Interested applicants are advised to monitor Grants.gov and SAMHSA’s funding pages for updates and publication of the full application package. The estimated post date for this opportunity is March 3, 2026. The application due date, award notification date, and project start date have not yet been disclosed. However, based on recurring patterns of similar SAMHSA programs, funding announcements and awards are typically aligned with the federal fiscal year, suggesting a possible award period beginning mid to late 2026. The total program funding is anticipated to be $3,000,000, and only one award is expected, indicating that this is likely a centralized, national-level initiative. The key contact for this opportunity is Belinda Greenfield, who can be reached at (240) 276-2545 or via email at [email protected].